Coronary stent Promus ELITE™

platinium-chromiumpolymerdrug eluting

Summary
The Promus ELITE™ Stent System is a platinum‑chromium (PtCr) coronary stent system combining a customized stent architecture with Everolimus drug elution and a permanent PVDF‑HFP polymer coating. The device is engineered for optimized deliverability, radial strength and clinical performance, supported by extensive PLATINUM clinical data.

Product Details
The system integrates a PtCr stent platform, Everolimus drug with PVDF‑HFP permanent polymer, and an enhanced delivery catheter designed to balance pushability, flexibility and trackability for precise placement in coronary lesions.

Key features

• Enhanced delivery system: optimized pushability, flexibility and trackability for improved lesion access.
• Customized stent architecture: engineered to balance strength, conformability and scaffolding.
• Drug and polymer: Everolimus combined with a permanent PVDF‑HFP polymer coating for controlled drug release.
• Platform material: Platinum Chromium (PtCr) for radial strength and visibility.
• Clinical evidence: extensive evaluation within the PLATINUM clinical trial program, including long‑term outcomes.

Ordering information (diameters, lengths and product codes)
(mm) | 8 | 12 | 16 | 20 | 24 | 28 | 32 | 38
2.25 | H7493941208220 | H7493941212220 | H7493941216220 | H7493941220220 | H7493941224220 | H7493941228220 | H7493941232220 | n/a
2.50 | H7493941208250 | H7493941212250 | H7493941216250 | H7493941220250 | H7493941224250 | H7493941228250 | H7493941232250 | H7493941238250
2.75 | H7493941208270 | H7493941212270 | H7493941216270 | H7493941220270 | H7493941224270 | H7493941228270 | H7493941232270 | H7493941238270
3.00 | H7493941208300 | H7493941212300 | H7493941216300 | H7493941220300 | H7493941224300 | H7493941228300 | H7493941232300 | H7493941238300
3.50 | H7493941208350 | H7493941212350 | H7493941216350 | H7493941220350 | H7493941224350 | H7493941228350 | H7493941232350 | H7493941238350
4.00 | H7493941208400 | H7493941212400 | H7493941216400 | H7493941220400 | H7493941224400 | H7493941228400 | H7493941232400 | H7493941238400

Clinical information
Nearly 10,000 patients have been evaluated across the PLATINUM clinical trial program, providing robust clinical evidence for safety and effectiveness across a wide patient population.

PLATINUM Workhorse Trial

• Objective: Assess safety and effectiveness of the Promus PtCr Everolimus‑Eluting Coronary Stent System for patients with up to two de novo lesions ≤24 mm and vessel diameters ≥2.50 mm to ≤4.25 mm, versus Xience CoCr EES.
• Design: Prospective, randomized, controlled, multicenter non‑inferiority trial.

Clinical outcomes
Five‑year results from the PLATINUM program report numerically lower event rates for the Promus ELITE™ Stent System within the PLATINUM family of studies.

Reimbursement
The C‑Code for the Promus ELITE™ Everolimus‑Eluting PtCr Coronary Stent System is C1874 (Stent, coated/covered with delivery system). C‑Codes are used for hospital outpatient device reporting for Medicare and some private payers; this is informational and not reimbursement or legal advice.

Key resources and documents

• Product Brochure (Promus ELITE™)
• Product Spec Sheet
• Directions for Use
• Indications, Safety and Warnings
• Latex Information: Promus ELITE™
• Metal Composition: Promus ELITE™
• MRI Safety: Promus ELITE™

Technical specifications

• Device name: Promus ELITE™ Everolimus‑Eluting Platinum Chromium Coronary Stent System
• Drug: Everolimus
• Polymer: PVDF‑HFP (permanent polymer)
• Platform material: Platinum Chromium (PtCr)
• Delivery system: enhanced for pushability, flexibility and trackability
• Available diameters: 2.25 mm, 2.50 mm, 2.75 mm, 3.00 mm, 3.50 mm, 4.00 mm
• Available lengths (mm): 8, 12, 16, 20, 24, 28, 32, 38 (availability varies by diameter; see ordering codes above)
• Clinical evidence: Extensive PLATINUM clinical trial program including PLATINUM Workhorse and related studies
• Regulatory/usage note: CAUTION — restricted to sale by or on the order of a physician; follow product labeling for indications, contraindications, warnings and instructions for use.